Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
Michael Schmueck‐Henneresse, Bilal Omer, Thomas Shum, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 1, pp. 348-362
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 293
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi, Selene Nuñez-Cruz, Roddy S. O’Connor, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 9, pp. 1100-1109
Open Access | Times Cited: 238
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy
Ann E. Metzloff, Marshall S. Padilla, Ningqiang Gong, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Open Access | Times Cited: 28
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
Sophia Stock, Michael Schmitt, Leopold Sellner
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 123
Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6317-6324
Open Access | Times Cited: 105
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists
Christopher T. Petersen, Mojibade Hassan, Anna B. Morris, et al.
Blood Advances (2018) Vol. 2, Iss. 3, pp. 210-223
Open Access | Times Cited: 96
Single-Cell Analysis of CAR-T Cell Activation Reveals A Mixed TH1/TH2 Response Independent of Differentiation
Iva Xhangolli, Burak Dura, GeeHee Lee, et al.
Genomics Proteomics & Bioinformatics (2019) Vol. 17, Iss. 2, pp. 129-139
Open Access | Times Cited: 87
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
Hong Qin, Zhenyuan Dong, Xiuli Wang, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Open Access | Times Cited: 82
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 125-125
Open Access | Times Cited: 81
Adoptive Immunotherapy beyond CAR T-Cells
Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 743-743
Open Access | Times Cited: 78
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
Fei Yi, Nicholas Frazzette, Anthony Cruz, et al.
Trends in Molecular Medicine (2018) Vol. 24, Iss. 7, pp. 642-653
Open Access | Times Cited: 77
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
Leila Amini, Dimitrios L. Wagner, Uta Rössler, et al.
Molecular Therapy (2020) Vol. 29, Iss. 1, pp. 32-46
Open Access | Times Cited: 42
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Veronika Bandara, Jade Foeng, Batjargal Gundsambuu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Effect of Binary Mechanical Environment on T Cell Function
Jatin Jawhir Pandit, Abed Alkader Yassin, Carlos Ureña Martín, et al.
Acta Biomaterialia (2025)
Closed Access
Recognition of different subsets of alloreactive T cells by activation-induced markers
Michiel G.H. Betjes, Mariska Klepper, Guillaume Smits, et al.
Transplant Immunology (2025), pp. 102227-102227
Open Access
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
Anna Mueller‐Schoell, Nahum Puebla‐Osorio, Robin Michelet, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2782-2782
Open Access | Times Cited: 30
A metabolic switch to memory CAR T cells: Implications for cancer treatment
Hosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, et al.
Cancer Letters (2020) Vol. 500, pp. 107-118
Closed Access | Times Cited: 29
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy
Sandhya Sharma, Mae Woods, Naren Mehta, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006267-e006267
Open Access | Times Cited: 9
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Alfredo Sebastian Colina, Viren Shah, Ravi K. Shah, et al.
Frontiers in Molecular Medicine (2024) Vol. 4
Open Access | Times Cited: 3
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
Lingli Yan, Bainan Liu
OncoTargets and Therapy (2018) Vol. Volume 12, pp. 193-204
Open Access | Times Cited: 25
Long-term exposure to “low-dose” bisphenol A decreases mitochondrial DNA copy number, and accelerates telomere shortening in human CD8 + T cells
Hoai Thi Thu Tran, Corinna Herz, Evelyn Lamy
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
Katie Palen, Joanna Zurko, Bryon D. Johnson, et al.
Cytotherapy (2021) Vol. 23, Iss. 11, pp. 985-990
Closed Access | Times Cited: 18
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells
Sophia Stock, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.
Human Gene Therapy (2018) Vol. 29, Iss. 10, pp. 1167-1182
Closed Access | Times Cited: 22
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
Thomas Mika, Swetlana Ladigan‐Badura, Abdelouahid Maghnouj, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 18
Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
Tao Yu, Shao-Kun Yu, Yan Xiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top